InSysBio to update its Cytocon DB and to present version 1.2.6.6

NEWS
Software
August 6, 2020

August 6, 2020

InSysBio is glad to present Cytocon DB 1.2.6.6! Cytocon DB team has reviewed 39 articles to introduce new data. It should be outlined that the total number of concentrations within the Database has already exceeded 10 thousand!

The DB was extended with new data, namely:

  • 9 diseases,
  • 13 tissues,
  • 20 molecules,
  • 7 cells,
  • 2525 concentrations,
  • 39 articles reviewed.

The table shows the actual number of components available in Cytocon DB 1.2.6.6.

To get more information about the latest version of Cytocon DB, please, visit its website.

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

September 2025
MoTuWeThFrSaSu
1
2
3
4
5
6
7
8
9
10
1. 10 Sep 2025 15:18 InSysBio to participate in ACoP 2025 InSysBio announces its participation in 2025 American Conference on Pharmacometrics (ACoP 2025) which is to be held from October 18-21, 2025 at the Gaylord Rockies, Aurora, Colorado, USA. InSysBio team is going to present its QSP modeling services & software to optimize drug development at the Booth #11 and 2 posters in frames of the Conference
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
     
Upcoming Events
18.10
InSysBio to participate in ACoP 2025
Tags
Latest News
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha
18.06
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology
03.06
InSysBio to present Integration of Cytocon DB and fIVE DB with Heta for QSP modeling